-
1Report
المؤلفون: National Cancer Institute (NCI)
المصدر: Phase I Trial of the Monoclonal Anti-Idiotype Antibody ACA125 in Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer
-
2Report
المصدر: A Randomised,Double Blind, Placebo Controlled, Multicentre Trial of Abagovomab Maintenance Therapy in Patients With Epithelial Ovarian Cancer After Complete Response to First Line Chemotherapy
Reinartz S, Kohler S, Schlebusch H, Krista K, Giffels P, Renke K, Huober J, Mobus V, Kreienberg R, DuBois A, Sabbatini P, Wagner U. Vaccination of patients with advanced ovarian carcinoma with the anti-idiotype ACA125: immunological response and survival (phase Ib/II). Clin Cancer Res. 2004 Mar 1;10(5):1580-7. doi: 10.1158/1078-0432.ccr-03-0056.
Wagner U, Kohler S, Reinartz S, Giffels P, Huober J, Renke K, Schlebusch H, Biersack HJ, Mobus V, Kreienberg R, Bauknecht T, Krebs D, Wallwiener D. Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: immune responses and survival in palliative treatment. See The biology behind: K. A. Foon and M. Bhattacharya-Chatterjee, Are solid tumor anti-idiotype vaccines ready for prime time? Clin. Cancer Res., 7:1112-1115, 2001. Clin Cancer Res. 2001 May;7(5):1154-62.
Pfisterer J, du Bois A, Sehouli J, Loibl S, Reinartz S, Reuss A, Canzler U, Belau A, Jackisch C, Kimmig R, Wollschlaeger K, Heilmann V, Hilpert F. The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR. Ann Oncol. 2006 Oct;17(10):1568-77. doi: 10.1093/annonc/mdl357.
Sabbatini P, Dupont J, Aghajanian C, Derosa F, Poynor E, Anderson S, Hensley M, Livingston P, Iasonos A, Spriggs D, McGuire W, Reinartz S, Schneider S, Grande C, Lele S, Rodabaugh K, Kepner J, Ferrone S, Odunsi K. Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer. Clin Cancer Res. 2006 Sep 15;12(18):5503-10. doi: 10.1158/1078-0432.CCR-05-2670.
Buzzonetti A, Fossati M, Catzola V, Scambia G, Fattorossi A, Battaglia A. Immunological response induced by abagovomab as a maintenance therapy in patients with epithelial ovarian cancer: relationship with survival-a substudy of the MIMOSA trial. Cancer Immunol Immunother. 2014 Oct;63(10):1037-45. doi: 10.1007/s00262-014-1569-0. Epub 2014 Jun 21.
Sabbatini P, Harter P, Scambia G, Sehouli J, Meier W, Wimberger P, Baumann KH, Kurzeder C, Schmalfeldt B, Cibula D, Bidzinski M, Casado A, Martoni A, Colombo N, Holloway RW, Selvaggi L, Li A, del Campo J, Cwiertka K, Pinter T, Vermorken JB, Pujade-Lauraine E, Scartoni S, Bertolotti M, Simonelli C, Capriati A, Maggi CA, Berek JS, Pfisterer J. Abagovomab as maintenance therapy in patients with epithelial ovarian cancer: a phase III trial of the AGO OVAR, COGI, GINECO, and GEICO--the MIMOSA study. J Clin Oncol. 2013 Apr 20;31(12):1554-61. doi: 10.1200/JCO.2012.46.4057. Epub 2013 Mar 11. -
3Report
المصدر: A Phase I/II Trial of ACA 125 in Patients With Recurrent Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer
Pfisterer J, du Bois A, Sehouli J, Loibl S, Reinartz S, Reuss A, Canzler U, Belau A, Jackisch C, Kimmig R, Wollschlaeger K, Heilmann V, Hilpert F. The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR. Ann Oncol. 2006 Oct;17(10):1568-77. doi: 10.1093/annonc/mdl357. -
4
المؤلفون: Mengxiong Li, Zhirong Qian, Hongling Guo, Xiaohui Tian, Tian Li, Songcheng Yin, Xiaoyu Xu
المصدر: Cancer Management and Research. 11:4119-4128
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Bevacizumab, business.industry, Hazard ratio, medicine.disease, Clinical trial, Pazopanib, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Maintenance therapy, Oregovomab, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Abagovomab, business, Ovarian cancer, medicine.drug
-
5
المؤلفون: Srustidhar Das, Surinder K. Batra
المصدر: Cancer Research. 75:4669-4674
مصطلحات موضوعية: Cancer Research, biology, medicine.medical_treatment, Membrane Proteins, Computational biology, medicine.disease, Article, Transmembrane protein, Targeted therapy, Oncology, Antigen, Oregovomab, CA-125 Antigen, Neoplasms, Immunology, biology.protein, medicine, Animals, Humans, Mesothelin, Molecular Targeted Therapy, Abagovomab, Antibody, Ovarian cancer, medicine.drug
-
6
المؤلفون: Alessandra Battaglia, Giovanni Scambia, Alexia Buzzonetti, Andrea Fattorossi, Marco Fossati, Valentina Catzola
المصدر: Cancer Immunology, Immunotherapy. 63:1037-1045
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, endocrine system diseases, medicine.medical_treatment, Immunology, Epitopes, T-Lymphocyte, Carcinoma, Ovarian Epithelial, Disease-Free Survival, Antibodies, Monoclonal, Murine-Derived, Double-Blind Method, Maintenance therapy, Internal medicine, medicine, Humans, Immunology and Allergy, Neoplasms, Glandular and Epithelial, Abagovomab, Survival analysis, Ovarian Neoplasms, business.industry, Antibodies, Monoclonal, Membrane Proteins, Immunotherapy, Survival Analysis, Clinical trial, Exact test, CTL, Treatment Outcome, CA-125 Antigen, Monoclonal, Female, business, T-Lymphocytes, Cytotoxic, medicine.drug
-
7Academic Journal
المؤلفون: Battaglia, Alessandra, Fossati, Marco, Buzzonetti, Alexia, Scambia, Giovanni, Fattorossi, Andrea
المساهمون: Battaglia, Alessandra, Fossati, Marco, Buzzonetti, Alexia, Scambia, Giovanni, Fattorossi, Andrea
مصطلحات موضوعية: Abagovomab, Immunotherapy, Interferon-Î3, Ovarian cancer, Personalised treatment, Predictive assay, Antibodies, Anti-Idiotypic, Monoclonal, Antineoplastic Agent, CA-125 Antigen, CD8-Positive T-Lymphocyte, Cancer Vaccine, Cells, Cultured, Enterotoxin, Female, Human, Immunocompetence, Interferon-gamma, Lymphocyte Activation, Membrane Protein, Neoplasm Staging, Ovarian Neoplasm, Survival Analysi, Vaccination, Immunology and Allergy, Immunology, Settore MED/40 - GINECOLOGIA E OSTETRICIA
Relation: info:eu-repo/semantics/altIdentifier/pmid/28919454; info:eu-repo/semantics/altIdentifier/wos/WOS:000414816100006; issue:191; firstpage:35; lastpage:39; numberofpages:5; issueyear:2017; journal:IMMUNOLOGY LETTERS; http://hdl.handle.net/10807/111940; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85029893086; www.elsevier.com/locate/immlet
-
8
المؤلفون: Giovanni Scambia, Alexia Buzzonetti, Andrea Fattorossi, Marco Fossati, Alessandra Battaglia
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_treatment, CD8-Positive T-Lymphocytes, Lymphocyte Activation, Antibodies, Monoclonal, Murine-Derived, Enterotoxins, 0302 clinical medicine, Monoclonal, Immunology and Allergy, Abagovomab, Interferon-γ, Cells, Cultured, Predictive assay, Ovarian Neoplasms, Cultured, Vaccination, Antibodies, Monoclonal, Antibodies, Anti-Idiotypic, medicine.anatomical_structure, Anti-Idiotypic, 030220 oncology & carcinogenesis, Female, Immunotherapy, Immunocompetence, medicine.drug, medicine.medical_specialty, medicine.drug_class, T cell, Cells, Immunology, Antineoplastic Agents, Monoclonal antibody, Cancer Vaccines, Antibodies, 03 medical and health sciences, Interferon-gamma, Immune system, Ovarian cancer, Internal medicine, medicine, Humans, Personalised treatment, CA-125 Antigen, Membrane Proteins, Neoplasm Staging, Survival Analysis, business.industry, Cancer, medicine.disease, 030104 developmental biology, Settore MED/40 - GINECOLOGIA E OSTETRICIA, business, CD8
-
9
المؤلفون: Cristina Goso, Jens Flemming, Christel C. Müller-Goymann, Karsten Gröger, Lena Wolff, Reinhard Schmitz
المصدر: Colloids and Surfaces A: Physicochemical and Engineering Aspects. 339:82-93
مصطلحات موضوعية: Chromatography, medicine.drug_class, Aluminium hydroxide, medicine.medical_treatment, Monoclonal antibody, Freeze-drying, chemistry.chemical_compound, Colloid and Surface Chemistry, Dextran, chemistry, Antigen, medicine, Potency, Abagovomab, Adjuvant, medicine.drug
-
10
المؤلفون: Jens Flemming, Christel C. Müller-Goymann, Karsten Gröger, Cristina Goso, Reinhard Schmitz, Lena Wolff
المصدر: Vaccine. 27:1834-1840
مصطلحات موضوعية: Ethylene Glycol, chemistry.chemical_element, Aluminum Hydroxide, Enzyme-Linked Immunosorbent Assay, Cancer Vaccines, Antibodies, Monoclonal, Murine-Derived, chemistry.chemical_compound, Adsorption, Adjuvants, Immunologic, In vivo, Interstitial fluid, Aluminium, Electrochemistry, medicine, Humans, Abagovomab, General Veterinary, General Immunology and Microbiology, Chemistry, Ligand, Aluminium hydroxide, Public Health, Environmental and Occupational Health, Antibodies, Monoclonal, Extracellular Fluid, Hydrogen-Ion Concentration, Antibodies, Anti-Idiotypic, Infectious Diseases, Chemical engineering, Ionic strength, Immunology, Thermodynamics, Molecular Medicine, Indicators and Reagents, Isoelectric Focusing, medicine.drug
-
11
المؤلفون: Felix Hilpert, A. du Bois, Rainer Kimmig, C. Jackisch, Antje Belau, Jacobus Pfisterer, Ulrich Canzler, S. Loibl, Jalid Sehouli, Alexander Reuss, Silke Reinartz, V. Heilmann, K. Wollschlaeger
المصدر: Annals of Oncology. 17:1568-1577
مصطلحات موضوعية: Adult, medicine.medical_specialty, Vaccination schedule, Phases of clinical research, Cancer Vaccines, Gastroenterology, Antibodies, Monoclonal, Murine-Derived, Antigen, Internal medicine, Injection site reaction, Vaccines, DNA, Clinical endpoint, Humans, Medicine, Neoplasms, Glandular and Epithelial, Abagovomab, Peritoneal Neoplasms, Aged, Aged, 80 and over, Ovarian Neoplasms, Immunity, Cellular, business.industry, Antibodies, Monoclonal, Hematology, Middle Aged, medicine.disease, Carcinoma, Papillary, Antibodies, Anti-Idiotypic, Vaccination, Oncology, CA-125 Antigen, Toxicity, Immunology, Patient Compliance, Female, Neoplasm Recurrence, Local, business, medicine.drug
-
12
المؤلفون: Jakob Dupont, Sally Schneider, Felicia Derosa, P. O. Livingston, Shashikant Lele, William P. McGuire, David R. Spriggs, Alexia Iasonos, S. Anderson, Martee L. Hensley, Soldano Ferrone, Paul Sabbatini, James L. Kepner, Cathy Grande, Kerry J. Rodabaugh, Carol Aghajanian, Silke Reinartz, Kunle Odunsi, Elizabeth A. Poynor
المصدر: Clinical Cancer Research. 12:5503-5510
مصطلحات موضوعية: Adult, myalgia, Cancer Research, medicine.medical_specialty, T-Lymphocytes, medicine.medical_treatment, Gastroenterology, Cohort Studies, Interferon-gamma, Route of administration, Internal medicine, medicine, Fallopian Tube Neoplasms, Humans, Abagovomab, Adverse effect, Peritoneal Neoplasms, Aged, Ovarian Neoplasms, Gynecology, Chemotherapy, business.industry, Drug Administration Routes, Immunogenicity, Histocompatibility Antigens Class II, Antibodies, Monoclonal, Middle Aged, Clinical trial, medicine.anatomical_structure, Oncology, CA-125 Antigen, Antibody Formation, Female, medicine.symptom, business, medicine.drug, Fallopian tube
-
13
المؤلفون: Uwe Wagner, Paul Sabbatini, Harald Schlebusch, Silke Reinartz, Jens Huober, Siegmund Köhler, Karl Krista, Patrick Giffels, Andreas duBois, Kirsten Renke, Rolf Kreienberg, Volker Möbus
المصدر: Clinical Cancer Research. 10:1580-1587
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, education.field_of_study, business.industry, Immunogenicity, Population, medicine.disease, Tumor antigen, Vaccination, Internal medicine, Ovarian carcinoma, Immunology, medicine, Carcinoma, Abagovomab, business, education, Survival analysis, medicine.drug
-
14
المؤلفون: Andrew M. Collins, Brian W.C. Tse, Alfred Zippelius, Martin K. Oehler, Viola Heinzelmann-Schwarz
المصدر: Annals of oncology : official journal of the European Society for Medical Oncology. 25(2)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Daclizumab, medicine.medical_treatment, Recombinant Fusion Proteins, Catumaxomab, Ipilimumab, Antineoplastic Agents, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Murine-Derived, Oregovomab, Internal medicine, Antibodies, Bispecific, medicine, Animals, Humans, Diphtheria Toxin, Abagovomab, Ovarian Neoplasms, Clinical Trials as Topic, business.industry, Cancer, Antibodies, Monoclonal, Hematology, Immunotherapy, medicine.disease, Clinical trial, Immunoglobulin G, Interleukin-2, Female, business, Ovarian cancer, medicine.drug
-
15
المؤلفون: Jose Maria Del Campo, Giovanni Scambia, Nicoletta Colombo, Klaus Baumann, Philipp Harter, Barbara Schmalfeldt, Cecilia Simonelli, Monica Bertolotti, Jonathan S. Berek, Luigi Selvaggi, Carlo Alberto Maggi, Angela Capriati, Christian Kurzeder, Jalid Sehouli, Andrew J. Li, Eric Pujade-Lauraine, Jacobus Pfisterer, Mariusz Bidziński, Robert W. Holloway, Paul Sabbatini, Werner Meier, David Cibula, Karel Cwiertka, Tamás Pintér, Andrea Martoni, Pauline Wimberger, Antonio Casado, Simona Scartoni, Jan B. Vermorken
المساهمون: Sabbatini, P, Harter, P, Scambia, G, Sehouli, J, Meier, W, Wimberger, P, Baumann, K, Kurzeder, C, Schmalfeldt, B, Cibula, D, Bidzinski, M, Casado, A, Martoni, A, Colombo, N, Holloway, R, Selvaggi, L, Li, A, Campo, J, Karel Cwiertka, N, Tamas Pinter, N, Null, J, Eric Pujade Lauraine, N, Simona Scartoni, N, Monica Bertolotti, N, Cecilia Simonelli, N, Angela Capriati, N, Carlo Alberto Maggi, N, Jacobus Pfisterer, N
المصدر: Journal of clinical oncology
مصطلحات موضوعية: Cancer Research, medicine.medical_treatment, Medizin, Carcinoma, Ovarian Epithelial, Gastroenterology, Antibodies, Monoclonal, Murine-Derived, chemistry.chemical_compound, Maintenance therapy, Antineoplastic Combined Chemotherapy Protocols, Medicine, Abagovomab, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Antibodies, Monoclonal, ORIGINAL REPORTS, Middle Aged, Prognosis, Adenocarcinoma, Mucinous, Survival Rate, Cystadenocarcinoma, Serou, ovarian cancer, Oncology, Female, medicine.drug, Human, medicine.medical_specialty, Prognosi, Follow-Up Studie, Double-Blind Method, Internal medicine, Injection site reaction, Humans, Endometrial Neoplasm, Adenocarcinoma, Mucinou, Survival rate, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocol, business.industry, Ovarian Neoplasm, Cancer, medicine.disease, Carboplatin, Cystadenocarcinoma, Serous, Endometrial Neoplasms, Surgery, Radiation therapy, Settore MED/40 - GINECOLOGIA E OSTETRICIA, chemistry, Human medicine, business, Ovarian cancer, Follow-Up Studies
-
16
المؤلفون: Hann, Evelin
المساهمون: Wagner, Uwe (Prof. Dr.)
مصطلحات موضوعية: CA125, Abagovomab, anti-idiotypische Antikörper, Eierstockkrebs, Abagovamag, anti-idiotypic, 2011, ddc:000, Allgemeines, Wissenschaft, Generalities -- Allgemeines, Wissenschaft
-
17
المؤلفون: Wirch, Daria
المساهمون: Wagner, Uwe (Prof. Dr.)
مصطلحات موضوعية: Immuntherapie, Treg, ovarian cancer, Abagovomab, Medical sciences, Medicine -- Medizin, Gesundheit, immune therapy, Ovarialkarzinom, ddc:610, biochemical phenomena, metabolism, and nutrition, treg, 2010, Medizin, Gesundheit
-
18
المصدر: Immunotherapy. 3(2)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, medicine.medical_treatment, Immunology, Antineoplastic Agents, Article, Antibodies, Monoclonal, Murine-Derived, Maintenance therapy, Internal medicine, medicine, Immunology and Allergy, Humans, Abagovomab, Ovarian Neoplasms, Chemotherapy, Clinical Trials as Topic, business.industry, Antibodies, Monoclonal, Immunotherapy, medicine.disease, Debulking, Antibodies, Anti-Idiotypic, Clinical trial, CA-125 Antigen, Monoclonal, Female, Ovarian cancer, business, medicine.drug
-
19
المؤلفون: Paul Sabbatini, Jonathan S. Berek, Philipp Harter, Martin Peters, Andreas du Bois, Jacobus Pfisterer, Cecilia Simonelli
المصدر: Expert opinion on biological therapy. 11(3)
مصطلحات موضوعية: Oncology, medicine.medical_specialty, Time Factors, Clinical Biochemistry, Context (language use), Antineoplastic Agents, Antibodies, Monoclonal, Murine-Derived, Immune system, Maintenance therapy, Internal medicine, Drug Discovery, medicine, Animals, Humans, Abagovomab, Pharmacology, Ovarian Neoplasms, Immunity, Cellular, Evidence-Based Medicine, business.industry, Specific immunotherapy, Cancer, Antibodies, Monoclonal, medicine.disease, Immunity, Humoral, Treatment Outcome, Tolerability, Immunology, Female, Neoplasm Recurrence, Local, Ovarian cancer, business, medicine.drug
-
20
المصدر: Experimental and therapeutic medicine. 2(2)
مصطلحات موضوعية: Oncology, Cancer Research, Chemotherapy, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Cancer, General Medicine, Review, Biology, medicine.disease, Clinical trial, Therapeutic approach, Immunology and Microbiology (miscellaneous), Maintenance therapy, Internal medicine, medicine, Abagovomab, Ovarian cancer, medicine.drug